MAPT and Alzheimer disease: Anti-amyloid interventions have failed so far to deliver tangible and substantial therapeutic benefits, highlighting the need for a more comprehensive understanding of Alzheimer’s disease (AD) mechanisms (1–3) that extends beyond the traditional amyloid (A), tau (T), neurodegeneration (N) (AT(N)) framework (4, 5).